These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5309481)

  • 1. Laboratory and clinical characteristics of attenuated strains of influenza virus.
    Maassab HF; Francis T; Davenport FM; Hennessy AV; Minuse E; Anderson G
    Bull World Health Organ; 1969; 41(3):589-94. PubMed ID: 5309481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of influenza virus mutants for possible use in a live virus vaccine.
    Mills J; Van Kirk J; Hill DA; Chanock RM
    Bull World Health Organ; 1969; 41(3):599-606. PubMed ID: 5309483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of live influenza vaccines.
    Smorodincev AA
    Bull World Health Organ; 1969; 41(3):585-8. PubMed ID: 5309480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interfering activity of virulent and attenuated influenza virus strains.
    Dekhtyareva NI; Medvedeva TE; Aleksandrova GI
    Acta Virol; 1976 Jun; 20(3):189-95. PubMed ID: 9798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).
    Youil R; Kiseleva I; Kwan WS; Szymkowiak C; Toner TJ; Su Q; Klimov A; Rudenko L; Shaw AR
    Virus Res; 2004 Jun; 102(2):165-76. PubMed ID: 15084398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peculiarities of obtaining and characterization of a cold-adapted A/PR/8/34 influenza virus variant.
    Egorov AYu ; Medvedeva TE; Polezhaev FI; Alexandrova GI; Ghendon YuZ
    Acta Virol; 1984 Jan; 28(1):19-25. PubMed ID: 6143493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of lentogenic Newcastle disease virus strain B-1 by cold adaptation.
    Gelb J; King DJ; Wisner WA; Ruggeri PA
    Avian Dis; 1996; 40(3):605-12. PubMed ID: 8883791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location of ts defects in the genome of cold-adapted recombinant influenza A virus vaccine strains.
    Medvedeva TE; Lisovskaya KV; Polezhaev FI; Garmashova LM; Alexandrova GI; Ghendon YZ
    Acta Virol; 1984 May; 28(3):204-11. PubMed ID: 6147996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro markers for measuring residual virulence for men of live attenuated influenza viruses.
    Boudreault A; Diaz-Rodriguez P; Lecomte J
    Dev Biol Stand; 1977 Jun 1-3; 39():33-40. PubMed ID: 604117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ts mutations in the genome of cold-adapted variants of human influenza virus A/Krasnodar/101/59 (H2N2) at different passage levels and their reproduction in lungs of hamsters.
    Panzig B; Döhner L; Lisovskaya KB; Ghendon YZ
    Acta Virol; 1984 Sep; 28(5):369-79. PubMed ID: 6151350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated influenza B virus recombinants obtained by crossing of B/England/2608/76 virus with a cold-adapted B/Leningrad/14/17/55 strain.
    Medvedeva TE; Gordon MA; Ghendon YZ; Klimov AI; Alexandrova GI
    Acta Virol; 1983 Jul; 27(4):311-7. PubMed ID: 6195900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a live attenuated influenza B virus vaccine candidate.
    Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
    Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
    J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of species and organ-specific features of tissue systems on the reactogenic and immunogenic properties of influenza virus.
    Gorev NE
    Acta Virol; 1975 Jan; 19(1):41-6. PubMed ID: 235196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on cold adapted variants of human influenza virus A/Krasnodar/101/59 (H2N2) with special reference to genetic stability of attenuation markers.
    Panzig B; Lisovskaya KB; Herrmann B; Klimov A; Döhner L
    Acta Virol; 1991 Aug; 35(4):332-42. PubMed ID: 1686959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity, immunogenicity and genetic stability in mice and ferrets of a cold inhibitor-resistant mutant of influenza H3N2 virus.
    Závadová H; Stárek M; Dolezalová B; Vonka V
    Dev Biol Stand; 1976; 33():151-4. PubMed ID: 955266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics and biological properties (genetic markers) of candidate strains for preparation of live influenza virus vaccines.
    Ghendon YZ
    Bull World Health Organ; 1984; 62(3):493-9. PubMed ID: 6331910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an attenuated strain for Japanese encephalitis live virus vaccine for porcine use.
    Fujisaki Y; Sugimori T; Morimoto T; Miura Y
    Natl Inst Anim Health Q (Tokyo); 1975; 15(1):15-23. PubMed ID: 1121330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of attenuated influenza viruses.
    Beare AS; Maassab HF; Tyrrell DA; Slepuskin AN; Hall TS
    Bull World Health Organ; 1971; 44(5):593-8. PubMed ID: 5316742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.